A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
A phase 1/2 trial of Pembrolizumab, Docetaxel in metastatic cancer, run by Krystal Biotech, Inc., now recruiting.
Overview
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs is a phase 1/2 interventional study registered as NCT06228326 by Krystal Biotech, Inc., with 250 participants planned, started 2024-04-17 and due to reach its primary completion in 2027-02. Interventions recorded: KB707, Pembrolizumab (KEYTRUDA®), Chemotherapy, Docetaxel. Conditions listed: Lung Cancer, Non-small Cell, Lung Cancer Metastatic, Solid Tumor, Adult, Advanced Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Shares Krystal Biotech, Pembrolizumab.
- TrialSKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors
Shares Docetaxel, Metastatic cancer (cancer that has spread).
- TrialSubstudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Shares Docetaxel, Metastatic cancer (cancer that has spread).
- TrialA Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Shares Docetaxel, Pembrolizumab, Metastatic cancer (cancer that has spread).
- TrialA Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Shares Docetaxel, Metastatic cancer (cancer that has spread).
- TrialA Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
Shares Docetaxel, Metastatic cancer (cancer that has spread).
- TrialA Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors
Shares Docetaxel, Metastatic cancer (cancer that has spread).
- TrialStudy of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
Shares Docetaxel, Pembrolizumab.